Class information for:
Level 1: BILIRUBIN//BILIVERDIN REDUCTASE//SERUM BILIRUBIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
16631 644 41.1 83%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
468 3       GLUCOSINOLATES//BILIRUBIN//HEME OXYGENASE 24157
1434 2             BILIRUBIN//HYPERBILIRUBINEMIA//KERNICTERUS 7874
16631 1                   BILIRUBIN//BILIVERDIN REDUCTASE//SERUM BILIRUBIN 644

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BILIRUBIN authKW 1949360 41% 16% 263
2 BILIVERDIN REDUCTASE authKW 854036 6% 49% 37
3 SERUM BILIRUBIN authKW 265501 2% 40% 14
4 BILIVERDIN REDUCTASE A authKW 243841 1% 86% 6
5 BIOPYRRINS authKW 233416 1% 62% 8
6 BILE PIGMENTS authKW 232733 3% 27% 18
7 TOTAL BILIRUBIN authKW 182094 2% 30% 13
8 GILBERTS SYNDROME authKW 167743 4% 13% 27
9 BILIVERDIN authKW 160177 4% 12% 28
10 UNIDAD INMUNOVIROL address 151723 1% 80% 4

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Peripheral Vascular Diseases 915 12% 0% 75
2 Cardiac & Cardiovascular System 616 13% 0% 85
3 Medical Laboratory Technology 527 5% 0% 32
4 Endocrinology & Metabolism 417 11% 0% 70
5 Biochemistry & Molecular Biology 313 22% 0% 141
6 Medicine, Research & Experimental 159 7% 0% 45
7 Biophysics 107 6% 0% 37
8 Gastroenterology & Hepatology 74 4% 0% 26
9 Pharmacology & Pharmacy 66 9% 0% 55
10 Medicine, General & Internal 65 6% 0% 41

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNIDAD INMUNOVIROL 151723 1% 80% 4
2 HEART FDN 97223 3% 10% 20
3 AREA BIOQUIM CLIN FISIOPATOL 94828 0% 100% 2
4 SERV INFECTOPEDIAT 94828 0% 100% 2
5 EMERGING FIELD OXIDAT ST S DNA STABIL 68961 1% 36% 4
6 ALTON OCHSNER FDN 47414 0% 100% 1
7 BIOCHEM CLILN BIOCHEM 47414 0% 100% 1
8 BIOMED NUTR METAB UNIT 47414 0% 100% 1
9 BUNDANG HOSPTIAL 47414 0% 100% 1
10 CARDIOLBUSAN PAIK HOSP 47414 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FRONTIERS IN PHARMACOLOGY 4373 2% 1% 12
2 ATHEROSCLEROSIS 2542 4% 0% 24
3 ANGIOLOGY 1020 2% 0% 10
4 CLINICAL BIOCHEMISTRY 909 2% 0% 10
5 ANNALS OF HEPATOLOGY 568 0% 0% 3
6 ADVANCES IN CLINICAL CHEMISTRY 555 0% 1% 2
7 JOURNAL OF MEDICAL BIOCHEMISTRY 546 0% 1% 2
8 LANCET HAEMATOLOGY 450 0% 1% 1
9 JOURNAL OF DIABETES AND ITS COMPLICATIONS 414 1% 0% 4
10 HEART AND VESSELS 410 1% 0% 4

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BILIRUBIN 1949360 41% 16% 263 Search BILIRUBIN Search BILIRUBIN
2 BILIVERDIN REDUCTASE 854036 6% 49% 37 Search BILIVERDIN+REDUCTASE Search BILIVERDIN+REDUCTASE
3 SERUM BILIRUBIN 265501 2% 40% 14 Search SERUM+BILIRUBIN Search SERUM+BILIRUBIN
4 BILIVERDIN REDUCTASE A 243841 1% 86% 6 Search BILIVERDIN+REDUCTASE+A Search BILIVERDIN+REDUCTASE+A
5 BIOPYRRINS 233416 1% 62% 8 Search BIOPYRRINS Search BIOPYRRINS
6 BILE PIGMENTS 232733 3% 27% 18 Search BILE+PIGMENTS Search BILE+PIGMENTS
7 TOTAL BILIRUBIN 182094 2% 30% 13 Search TOTAL+BILIRUBIN Search TOTAL+BILIRUBIN
8 GILBERTS SYNDROME 167743 4% 13% 27 Search GILBERTS+SYNDROME Search GILBERTS+SYNDROME
9 BILIVERDIN 160177 4% 12% 28 Search BILIVERDIN Search BILIVERDIN
10 BILIVERDIN IX BETA REDUCTASE 142242 0% 100% 3 Search BILIVERDIN+IX+BETA+REDUCTASE Search BILIVERDIN+IX+BETA+REDUCTASE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WAGNER, KH , WALLNER, M , MOLZER, C , GAZZIN, S , BULMER, AC , TIRIBELLI, C , VITEK, L , (2015) LOOKING TO THE HORIZON: THE ROLE OF BILIRUBIN IN THE DEVELOPMENT AND PREVENTION OF AGE-RELATED CHRONIC DISEASES.CLINICAL SCIENCE. VOL. 129. ISSUE 1. P. 1 -25 103 59% 8
2 KUNDUR, AR , SINGH, I , BULMER, AC , (2015) BILIRUBIN, PLATELET ACTIVATION AND HEART DISEASE: A MISSING LINK TO CARDIOVASCULAR PROTECTION IN GILBERT'S SYNDROME?.ATHEROSCLEROSIS. VOL. 239. ISSUE 1. P. 73 -84 76 58% 10
3 BOON, AC , BULMER, AC , COOMBES, JS , FASSETT, RG , (2014) CIRCULATING BILIRUBIN AND DEFENSE AGAINST KIDNEY DISEASE AND CARDIOVASCULAR MORTALITY: MECHANISMS CONTRIBUTING TO PROTECTION IN CLINICAL INVESTIGATIONS.AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. VOL. 307. ISSUE 2. P. F123 -F136 73 43% 8
4 WEGIEL, B , OTTERBEIN, LE , (2012) GO GREEN: THE ANTI-INFLAMMATORY EFFECTS OF BILIVERDIN REDUCTASE.FRONTIERS IN PHARMACOLOGY. VOL. 3. ISSUE . P. - 43 69% 20
5 VITEK, L , (2012) THE ROLE OF BILUBININ DIABETES, METABOLIC SYNDROME, AND CARDIOVASCULAR DISEASES.FRONTIERS IN PHARMACOLOGY. VOL. 3. ISSUE . P. - 44 57% 60
6 ODA, E , (2015) CROSS-SECTIONAL AND LONGITUDINAL ASSOCIATIONS BETWEEN SERUM BILIRUBIN AND DYSLIPIDEMIA IN A HEALTH SCREENING POPULATION.ATHEROSCLEROSIS. VOL. 239. ISSUE 1. P. 31 -37 31 86% 3
7 RYTER, SW , (2012) BILE PIGMENTS IN PULMONARY AND VASCULAR DISEASE.FRONTIERS IN PHARMACOLOGY. VOL. 3. ISSUE . P. - 48 58% 7
8 KRUZLIAK, P , KANG, SJ , LEE, C , (2014) EFFECTS OF SERUM BILIRUBIN ON ATHEROSCLEROTIC PROCESSES.ANNALS OF MEDICINE. VOL. 46. ISSUE 3. P. 138 -147 43 57% 8
9 LIN, JP , VITEK, L , SCHWERTNER, HA , (2010) SERUM BILIRUBIN AND GENES CONTROLLING BILIRUBIN CONCENTRATIONS AS BIOMARKERS FOR CARDIOVASCULAR DISEASE.CLINICAL CHEMISTRY. VOL. 56. ISSUE 10. P. 1535 -1543 39 58% 58
10 MAINES, MD , (2010) POTENTIAL APPLICATION OF BILIVERDIN REDUCTASE AND ITS FRAGMENTS TO MODULATE INSULIN/IGF-1/MAPK/PI3-K SIGNALING PATHWAYS IN THERAPEUTIC SETTINGS.CURRENT DRUG TARGETS. VOL. 11. ISSUE 12. P. 1586 -1594 42 60% 14

Classes with closest relation at Level 1


Rank Class id link
1 339 HEME OXYGENASE//HEME OXYGENASE 1//CARBON MONOXIDE
2 14067 GILBERTS SYNDROME//UGT1A1//UGT1A1 GENE
3 17924 LIVER GROWTH FACTOR//SERV BIOQUIM EXPT//DELTA BILIRUBIN
4 13874 DIPYRRINONE//BILE PIGMENTS//MONATSHEFTE FUR CHEMIE
5 2352 KERNICTERUS//HYPERBILIRUBINEMIA//NEONATAL JAUNDICE
6 34637 D ROMS TEST//D ROMS//ALCOHOL ABUSE ALCOHOLISM NEUROL SCI
7 36822 DONGSAN KIDNEY//DONG SAN KIDNEY//CATALASE H2O2
8 22224 ISCHEMIC HEPATITIS//HYPOXIC HEPATITIS//SHOCK LIVER
9 33227 NON PROTEIN BOUND IRON//APOCARBONIC ANHYDRASE//APOENZYME REACTIVATION METHOD
10 11725 GAMMA GLUTAMYLTRANSFERASE//GAMMA GLUTAMYL TRANSFERASE//ALANINE AMINOTRANSFERASE

Go to start page